Debates over drug pricing have prompted Swissinfo readers to ask whether pharma companies can set prices for new drugs as high as they want.
Series Truth or tale,
Episode 11:
Ongoing discussions around drug prices prompted some Swissinfo readers to ask if it's true that pharma companies can set prices for new drugs as high as they want.
This content was published on
May 6, 2026 - 14:17
Swiss pharma companies warn current pricing rules delay access to new medicines.
Boss of Swiss pharma research association bemoans political pressure of drug prices.
Tackling the misuse of patents by some big pharma companies could go a long way to bringing down drug prices.
Die Pharmaindustrie nutzt den Druck der Regierung Trump geschickt, um in Europa für teurere Arzneimittel zu lobbyieren. Statt…
Trump puts pressure on Swiss companies to raise pharma prices in Europe
Interpharma warns Switzerland may face a US Section 301 trade probe targeting drug pricing, threatening $35.5 billion in pharma…
